| Absorption |
| Blood-Brain Barrier | BBB+ | 0.7327 |
| Human Intestinal Absorption | HIA+ | 0.7436 |
| Caco-2 Permeability | Caco2- | 0.6105 |
| P-glycoprotein Substrate | Non-substrate | 0.7932 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9156 |
| Non-inhibitor | 0.9952 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9403 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4895 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7953 |
| CYP450 2D6 Substrate | Non-substrate | 0.8073 |
| CYP450 3A4 Substrate | Non-substrate | 0.6508 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7183 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8621 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9133 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8371 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9755 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9613 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8422 |
| Non-inhibitor | 0.8555 |
| AMES Toxicity | Non AMES toxic | 0.7554 |
| Carcinogens | Carcinogens | 0.7322 |
| Fish Toxicity | High FHMT | 0.7558 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.5528 |
| Honey Bee Toxicity | High HBT | 0.5351 |
| Biodegradation | Not ready biodegradable | 0.8008 |
| Acute Oral Toxicity | III | 0.5986 |
| Carcinogenicity (Three-class) | Non-required | 0.6868 |